Skip to main content
XRNChiron Real Estate Inc.Sell5.4·$37.97-0.34%
Open full analysis

Chiron Real Estate Inc. (XRN) Stock Analysis

Breakout setup

SellModerate Confidence

Real Estate · REIT - Healthcare Facilities

Sell if holding. Analyst target reached at $37.97 — A.R:R is negative (-1.5) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Near 52-week high (4.9% away).

Chiron Real Estate Inc. is a net-lease medical REIT that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems. Chiron Real Estate Inc. was established on March 18, 2011, incorporated in Maryland and is based... Read more

$37.97-0.2% A.UpsideScore 5.4/10#8 of 16 REIT - Healthcare Facilities
QualityF-score6 / 9FCF yield17.72%
IncomeYield15.09%(5y avg 10.00%)Payout1114.29%
Stop $35.99Target $37.88(resistance)A.R:R -1.5:1
Analyst target$37.88-0.3%8 analysts
$37.88our TP
$37.97price
$37.88mean
$9
$46

Sell if holding. Analyst target reached at $37.97 — A.R:R is negative (-1.5) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Near 52-week high (4.9% away). Chart setup: Golden cross, above all MAs, RSI 58, MACD bullish. Score 5.4/10, moderate confidence.

Passes 7/8 gates (positive momentum, clean insider activity, no SEC red flags, news events none recent, earnings proximity 31d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: aggressive.

TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Tue, Aug 4, 202631d to earnings· next earnings call

Thesis

Rewards
Positive insider activity
Risks
Analyst target reached - limited upside remaining
Near 52-week high (4.9% away)
Leverage penalty (D/E 1.3): -0.5

Key Metrics

P/E (TTM)
P/E (Fwd)-24.8
Mkt Cap$550M
EV/EBITDA14.3
Profit Mgn-5.1%
ROE-1.7%
Rev Growth10.1%
Beta1.12
Dividend15.09%
Rating analysts13

Quality Signals

Piotroski F6/9MoatNarrow

Options Flow

P/C0.38bullish
IV58%elevated

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

1 floor-breaker

No near-term catalyst priced in. Thesis progression will come from fundamentals grinding, not event reaction.static

Earnings History
0.0
Surprise Avg
0.0
Erm
3.5
Earnings Timing
5.0
Dividend Safety
5.2
Earnings concerns: 0B/4MDividend: 1509.0%
GatesA.R:R -1.5=NEGATIVEMomentum 7.0>=5.5Insider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 31d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARBreakoutSuitability: Aggressive
RSI
58 · Neutral
20D MA 50D MA 200D MAGOLDEN CROSSSupport $34.57Resistance $38.65

Price Targets

$36
$38
A.Upside-0.2%
A.R:R-1.5:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! Target reached (-13.2% upside)
! Negative risk/reward — downside exceeds upside

Earnings

M
M
M
M
0/4 beats
Next Earnings2026-08-04 (31d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is XRN stock a buy right now?

Sell if holding. Analyst target reached at $37.97 — A.R:R is negative (-1.5) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Near 52-week high (4.9% away). Chart setup: Golden cross, above all MAs, RSI 58, MACD bullish. Prior stop was $35.99. Score 5.4/10, moderate confidence.

What is the XRN stock price target?

Take-profit target: $37.88 (-0.2% upside). Prior stop was $35.99. Stop-loss: $35.99.

What are the risks of investing in XRN?

Analyst target reached - limited upside remaining; Near 52-week high (4.9% away); Leverage penalty (D/E 1.3): -0.5.

Is XRN overvalued or undervalued?

Chiron Real Estate Inc. trades at a P/E of N/A (forward -24.8). TrendMatrix value score: 4.5/10. Verdict: Sell.

What do analysts say about XRN?

13 analysts cover XRN with a consensus score of 3.7/5. Average price target: $38.

What does Chiron Real Estate Inc. do?Chiron Real Estate Inc. is a net-lease medical REIT that acquires healthcare facilities and leases those facilities to...

Chiron Real Estate Inc. is a net-lease medical REIT that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems. Chiron Real Estate Inc. was established on March 18, 2011, incorporated in Maryland and is based in Bethesda, Maryland.

Related stocks: SBRA (Sabra Health Care REIT, Inc.) · MPT (Medical Properties Trust, Inc.) · CHCT (Community Healthcare Trust Inco) · UHT (Universal Health Realty Income ) · NHI (National Health Investors, Inc.)
Home Stocks XRN

Latest news

No recent news